Skip to main content
Amplia reports breakthrough results in pancreatic cancer trial
Image for illustrative purposes only. Not a real photo.

Amplia reports breakthrough results in pancreatic cancer trial

Share

Melbourne-based Amplia Therapeutics (ASX:ATX) announced a clinical breakthrough in the treatment of advanced pancreatic cancer.